Xilio Therapeutics (XLO) Net Equity Issued and Repurchased (2020 - 2026)
Xilio Therapeutics (XLO) reported Net Equity Issued and Repurchased of $35,000 for Q2 2026, unchanged from $35,000 a year earlier.
Powered by 
Analysis
Xilio Therapeutics (XLO) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Xilio Therapeutics' Net Equity Issued and Repurchased came in at $35.82 million; for FY2025, it was $35.83 million.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 29.2% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $68,000 in FY2024 (-64.9%), $194,000 in FY2023, $16,000 in FY2022 (-100.0%) and $144.89 million in FY2021.
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$14.57 million in Q2 2024 and a high of $35.79 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Xilio Therapeutics | 157.76 Mn | -369.91 Mn | - | 36,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 35.87 Mn |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | -4.27 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 54,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 116.60 Mn |
| Sep 30, 2021 | 14,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 144.91 Mn |
| Dec 31, 2020 | 153,000.00 |
API Access
Xilio Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=XLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "XLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=XLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();